Endoscopic Surveillance of Duodenal Polyposis After Total Gastrectomy in Familial Adenomatous Polyposis

被引:0
|
作者
Shah, Ravi S. [1 ]
Mehta, Neal [2 ]
Mankaney, Gautam [2 ]
Walsh, Matthew R. [3 ]
Burke, Carol A. [2 ]
Bhatt, Amit [2 ]
机构
[1] Cleveland Clin, Med Inst, Dept Internal Med, Cleveland, OH 44106 USA
[2] Cleveland Clin, Dept Gastroenterol Hepatol & Nutr, Digest Dis & Surg Inst, Cleveland, OH 44106 USA
[3] Cleveland Clin, Digest Dis & Surg Inst, Dept Gen Surg, Cleveland, OH 44106 USA
关键词
CANCER;
D O I
10.14309/crj.0000000000000445
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
The lifetime incidence of duodenal polyposis in familial adenomatous polyposis (FAP) approaches 100%, and duodenal cancer is the most common malignancy once colectomy is performed. The incidence of gastric cancer is increasing in patients with FAP, and when gastric polyps with high-grade dysplasia or cancer are present, a total gastrectomy with Roux-en-Y esophagojejunostomy is indicated. The altered anatomy after surgery and presence of adhesions from a previous colectomy make endoscopic surveillance of the duodenum with standard equipment difficult. This case report highlights an approach to duodenal polyposis surveillance in FAP after total gastrectomy with Roux-en-Y esophagojejunostomy.
引用
收藏
页数:3
相关论文
共 50 条
  • [31] Endoscopic Approach to Duodenal Adenomas in Familial Adenomatous Polyposis: A Retrospective Cohort
    Garcia, Joana Lemos
    Rosa, Isadora
    da Silva, Joao Pereira
    Lage, Pedro
    Claro, Isabel
    GE PORTUGUESE JOURNAL OF GASTROENTEROLOGY, 2023, 30 (06) : 430 - 436
  • [32] Duodenal polyposis in familial adenomatous polyposis: Risks and present management.
    Buecher, B
    Lehur, PA
    GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE, 1997, 21 (12): : 967 - 977
  • [33] MIGHT ANTACIDS REDUCE DUODENAL POLYPOSIS IN PATIENTS WITH FAMILIAL ADENOMATOUS POLYPOSIS
    SCATES, DK
    VENITT, S
    PHILLIPS, RKS
    SPIGELMAN, AD
    BRITISH JOURNAL OF SURGERY, 1995, 82 (05) : 701 - 701
  • [34] Tailored surgical treatment of duodenal polyposis in familial adenomatous polyposis syndrome
    Augustin, Toms
    Moslim, Maitham A.
    Tang, Andrew
    Walsh, R. Matthew
    SURGERY, 2018, 163 (03) : 594 - 599
  • [35] Celecoxib for the chemopreventive management of duodenal polyposis in familial adenomatous polyposis (FAR)
    Hur, C
    Chung, DC
    Hsu, EH
    Evans, JA
    Gazelle, GS
    GASTROENTEROLOGY, 2005, 128 (04) : A297 - A297
  • [36] An aggressive approach to advanced duodenal polyposis in familial adenomatous polyposis.
    Soravia, C
    Berk, T
    Haber, G
    Cohen, Z
    Gallinger, S
    GASTROENTEROLOGY, 1996, 110 (04) : A596 - A596
  • [37] Management of duodenal adenomas in familial adenomatous polyposis
    Saurin, JC
    Chayvialle, JA
    Ponchon, T
    ENDOSCOPY, 1999, 31 (06) : 472 - 478
  • [38] Long-term compliance with endoscopic surveillance for familial adenomatous polyposis
    Douma, K. F. L.
    Bleiker, E. M. A.
    Aaronson, N. K.
    Cats, A.
    Gerritsma, M. A.
    Gundy, C. M.
    Vasen, H. F. A.
    COLORECTAL DISEASE, 2010, 12 (12) : 1198 - 1207
  • [39] DUODENAL SURVEILLANCE IN FAMILIAL ADENOMATOUS POLYPOSIS: ADHERENCE TO THE ESGE GUIDELINES IN A TERTIARY CENTER
    Awadelkarim, Bidour
    Charnley, Richard
    Brennan, Paul
    Leeds, John
    Oppong, Kofi
    Nayar, Manu
    GUT, 2022, 71 : A96 - A97
  • [40] Prospective enteroscopic evaluation of jejunal polyposis in patients with familial adenomatous polyposis and advanced duodenal polyposis
    Alderlieste, Y. A.
    Rauws, E. A. J.
    Mathus-Vliegen, E. M. H.
    Fockens, P.
    Dekker, E.
    FAMILIAL CANCER, 2013, 12 (01) : 51 - 56